• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

围手术期抗生素预防应用中头孢呋辛的基于生理学的药代动力学评价。

Physiologically based pharmacokinetic evaluation of cefuroxime in perioperative antibiotic prophylaxis.

机构信息

Department of Pharmaceutical and Medical Chemistry-Clinical Pharmacy, Muenster, Germany.

Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Muenster, Muenster, Germany.

出版信息

Br J Clin Pharmacol. 2019 Dec;85(12):2864-2877. doi: 10.1111/bcp.14121. Epub 2019 Dec 15.

DOI:10.1111/bcp.14121
PMID:31487057
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6955413/
Abstract

AIMS

Adequate plasma concentrations of antibiotics during surgery are essential for the prevention of surgical site infections. We examined the pharmacokinetics of 1.5 g cefuroxime administered during induction of anaesthesia with follow-up doses every 2.5 hours until the end of surgery. We built a physiologically based pharmacokinetic model with the aim to ensure adequate antibiotic plasma concentrations in a heterogeneous population.

METHODS

A physiologically based pharmacokinetic model (PK-Sim /MoBi ) was developed to investigate unbound plasma concentrations of cefuroxime. Blood samples from 25 thoracic surgical patients were analysed with high-performance liquid chromatography. To evaluate optimized dosing regimens, physiologically based pharmacokinetic model simulations were conducted.

RESULTS

Dosing simulations revealed that a standard dosing regimen of 1.5 g every 2.5 hours reached the pharmacokinetic/pharmacodynamic target for Staphylococcus aureus. However, for Escherichia coli, >50% of the study participants did not reach predefined targets. Effectiveness of cefuroxime against E. coli can be improved by administering a 1.5 g bolus immediately followed by a continuous infusion of 3 g cefuroxime over 3 hours.

CONCLUSION

The use of cefuroxime for perioperative antibiotic prophylaxis to prevent staphylococcal surgical site infections appears to be effective with standard dosing of 1.5 g preoperatively and follow-up doses every 2.5 hours. In contrast, if E. coli is relevant in surgeries, this dosing regimen appears insufficient. With our derived dose recommendations, we provide a solution for this issue.

摘要

目的

手术期间抗生素的血浆浓度应足够高,以预防手术部位感染。我们研究了麻醉诱导时给予 1.5g 头孢呋辛,随后每 2.5 小时给予一次维持剂量直至手术结束时的药代动力学。我们构建了一个基于生理的药代动力学模型,旨在确保在异质人群中达到足够的抗生素血浆浓度。

方法

开发了一个基于生理的药代动力学模型(PK-Sim / MoBi)来研究头孢呋辛的游离血浆浓度。对 25 例胸外科患者的血样进行了高效液相色谱分析。为了评估优化的给药方案,进行了基于生理的药代动力学模型模拟。

结果

给药模拟显示,每 2.5 小时给予 1.5g 的标准剂量方案可达到金黄色葡萄球菌的药代动力学/药效学目标。然而,对于大肠杆菌,超过 50%的研究参与者未达到预设目标。通过立即给予 1.5g 头孢呋辛的负荷剂量,然后连续输注 3g 头孢呋辛 3 小时,可以提高头孢呋辛对大肠杆菌的疗效。

结论

在预防金黄色葡萄球菌手术部位感染的围手术期预防性使用头孢呋辛时,术前给予标准剂量 1.5g,随后每 2.5 小时给予一次维持剂量,似乎是有效的。相比之下,如果大肠杆菌在手术中相关,这种给药方案似乎不足够。我们提出的剂量建议提供了解决这个问题的方案。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0734/6955413/ea8e99ff593c/BCP-85-2864-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0734/6955413/06e8605c4808/BCP-85-2864-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0734/6955413/92fd62ef7cce/BCP-85-2864-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0734/6955413/07238ec87648/BCP-85-2864-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0734/6955413/88d58a7a4816/BCP-85-2864-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0734/6955413/ea8e99ff593c/BCP-85-2864-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0734/6955413/06e8605c4808/BCP-85-2864-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0734/6955413/92fd62ef7cce/BCP-85-2864-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0734/6955413/07238ec87648/BCP-85-2864-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0734/6955413/88d58a7a4816/BCP-85-2864-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0734/6955413/ea8e99ff593c/BCP-85-2864-g005.jpg

相似文献

1
Physiologically based pharmacokinetic evaluation of cefuroxime in perioperative antibiotic prophylaxis.围手术期抗生素预防应用中头孢呋辛的基于生理学的药代动力学评价。
Br J Clin Pharmacol. 2019 Dec;85(12):2864-2877. doi: 10.1111/bcp.14121. Epub 2019 Dec 15.
2
Population pharmacokinetic evaluation of cefuroxime in perioperative antibiotic prophylaxis during and after cardiopulmonary bypass.心脏体外循环期间和之后围手术期抗生素预防应用中头孢呋辛的群体药代动力学评价。
Br J Clin Pharmacol. 2021 Mar;87(3):1486-1498. doi: 10.1111/bcp.14556. Epub 2020 Nov 17.
3
Population pharmacokinetic models for cefuroxime and metronidazole used in combination as prophylactic agents in colorectal surgery: Model-based evaluation of standard dosing regimens.头孢呋辛和甲硝唑联合用于结直肠手术的预防剂的群体药代动力学模型:基于模型的标准剂量方案评价。
Int J Antimicrob Agents. 2015 May;45(5):504-11. doi: 10.1016/j.ijantimicag.2015.01.008. Epub 2015 Feb 16.
4
Pharmacokinetics of cefuroxime in infants and neonates undergoing cardiac surgery.头孢呋辛在心脏手术婴儿和新生儿中的药代动力学。
Br J Clin Pharmacol. 2018 Sep;84(9):2020-2028. doi: 10.1111/bcp.13632. Epub 2018 Jun 15.
5
Targeting cefuroxime plasma concentrations during coronary artery bypass graft surgery with cardiopulmonary bypass.在体外循环冠状动脉搭桥手术期间靶向头孢呋辛血浆浓度。
Int J Clin Pharm. 2015 Aug;37(4):592-8. doi: 10.1007/s11096-015-0101-8. Epub 2015 Mar 20.
6
Pharmacodynamic model for β-lactam regimens used in surgical prophylaxis: model-based evaluation of standard dosing regimens.用于外科手术预防的β-内酰胺类给药方案的药效学模型:基于模型的标准给药方案评估
Int J Clin Pharm. 2018 Oct;40(5):1059-1071. doi: 10.1007/s11096-018-0720-y. Epub 2018 Aug 16.
7
Colo-Pro: a pilot randomised controlled trial to compare standard bolus-dosed cefuroxime prophylaxis to bolus-continuous infusion-dosed cefuroxime prophylaxis for the prevention of infections after colorectal surgery.Colo-Pro:一项比较标准推注剂量头孢呋辛预防与推注持续输注剂量头孢呋辛预防结直肠手术后感染的前瞻性随机对照试验。
Eur J Clin Microbiol Infect Dis. 2019 Feb;38(2):357-363. doi: 10.1007/s10096-018-3435-z. Epub 2018 Dec 5.
8
The Importance of Perioperative Prophylaxis with Cefuroxime or Ceftriaxone in the Surgical Site Infections Prevention after Cranial and Spinal Neurosurgical Procedures.头孢呋辛或头孢曲松围手术期预防在颅脑和脊柱神经外科手术后手术部位感染预防中的重要性。
Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2017 Sep 1;38(2):85-97. doi: 10.1515/prilozi-2017-0026.
9
Bone, subcutaneous tissue and plasma pharmacokinetics of cefuroxime in total knee replacement patients - a randomized controlled trial comparing continuous and short-term infusion.全膝关节置换患者头孢呋辛的骨、皮下组织和血浆药代动力学 - 一项比较连续和短期输注的随机对照试验。
APMIS. 2019 Dec;127(12):779-788. doi: 10.1111/apm.12996. Epub 2019 Oct 14.
10
Influence of cardiopulmonary bypass on cefuroxime plasma concentration and pharmacokinetics in patients undergoing coronary surgery.体外循环对行冠状动脉手术患者头孢呋辛血药浓度及药代动力学的影响。
Eur J Cardiothorac Surg. 2012 Aug;42(2):300-5. doi: 10.1093/ejcts/ezr319. Epub 2012 Jan 26.

引用本文的文献

1
PK/PD-Guided Strategies for Appropriate Antibiotic Use in the Era of Antimicrobial Resistance.抗菌药物耐药时代基于药代动力学/药效学指导的合理使用抗生素策略
Antibiotics (Basel). 2025 Jan 14;14(1):92. doi: 10.3390/antibiotics14010092.
2
Infectiological Outcome of Total Hip and Total Knee Arthroplasty in Post-Traumatic and Primary Osteoarthritis.创伤后和原发性骨关节炎患者全髋关节和全膝关节置换术的感染学结果
Antibiotics (Basel). 2024 Dec 5;13(12):1186. doi: 10.3390/antibiotics13121186.
3
Higher cefazolin concentrations in synovial fluid with intraosseous regional prophylaxis in knee arthroplasty: a randomized controlled trial.

本文引用的文献

1
Individualising Therapy to Minimize Bacterial Multidrug Resistance.个体化治疗以最小化细菌的多重耐药性。
Drugs. 2018 Apr;78(6):621-641. doi: 10.1007/s40265-018-0891-9.
2
Therapeutic Drug Monitoring of Beta-Lactams and Other Antibiotics in the Intensive Care Unit: Which Agents, Which Patients and Which Infections?β-内酰胺类和其他抗生素在重症监护病房的治疗药物监测:哪些药物、哪些患者和哪些感染?
Drugs. 2018 Mar;78(4):439-451. doi: 10.1007/s40265-018-0880-z.
3
The Prevalence of Nosocomial Infection and Antibiotic Use in German Hospitals.
关节腔内骨水泥局部预防给药在膝关节置换术中增加关节滑液中头孢唑啉浓度:一项随机对照试验。
Arch Orthop Trauma Surg. 2024 Sep;144(9):4069-4075. doi: 10.1007/s00402-023-05108-1. Epub 2023 Oct 30.
4
The Role of PK/PD Analysis in the Development and Evaluation of Antimicrobials.药代动力学/药效学分析在抗菌药物研发与评价中的作用
Pharmaceutics. 2021 Jun 3;13(6):833. doi: 10.3390/pharmaceutics13060833.
5
Pharmacokinetic Model for Cefuroxime Dosing during Cardiac Surgery under Cardiopulmonary Bypass.心脏手术体外循环期间头孢呋辛给药的药代动力学模型。
Antimicrob Agents Chemother. 2020 Nov 17;64(12). doi: 10.1128/AAC.01687-20.
德国医院的医院感染和抗生素使用情况。
Dtsch Arztebl Int. 2017 Dec 15;114(50):851-857. doi: 10.3238/arztebl.2017.0851.
4
Prolonged versus short-term intravenous infusion of antipseudomonal β-lactams for patients with sepsis: a systematic review and meta-analysis of randomised trials.长程与短程静脉输注抗假单胞菌β-内酰胺类药物治疗脓毒症患者的随机对照试验的系统评价和荟萃分析。
Lancet Infect Dis. 2018 Jan;18(1):108-120. doi: 10.1016/S1473-3099(17)30615-1. Epub 2017 Nov 5.
5
Adhering to a national surgical care bundle reduces the risk of surgical site infections.坚持国家外科护理综合措施可降低手术部位感染的风险。
PLoS One. 2017 Sep 6;12(9):e0184200. doi: 10.1371/journal.pone.0184200. eCollection 2017.
6
Timing of preoperative antibiotic prophylaxis in 54,552 patients and the risk of surgical site infection: A systematic review and meta-analysis.54552例患者术前抗生素预防的时机与手术部位感染风险:一项系统评价和荟萃分析
Medicine (Baltimore). 2017 Jul;96(29):e6903. doi: 10.1097/MD.0000000000006903.
7
Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection, 2017.美国疾病预防控制中心 2017 年《手术部位感染预防指南》。
JAMA Surg. 2017 Aug 1;152(8):784-791. doi: 10.1001/jamasurg.2017.0904.
8
Physiologically Based Pharmacokinetic Modeling of Renally Cleared Drugs in Pregnant Women.生理药代动力学模型在孕妇肾清除药物中的应用。
Clin Pharmacokinet. 2017 Dec;56(12):1525-1541. doi: 10.1007/s40262-017-0538-0.
9
Timing of surgical antimicrobial prophylaxis: a phase 3 randomised controlled trial.手术抗菌预防时机:一项 3 期随机对照试验。
Lancet Infect Dis. 2017 Jun;17(6):605-614. doi: 10.1016/S1473-3099(17)30176-7. Epub 2017 Apr 3.
10
Development of a Physiologically Based Pharmacokinetic Modelling Approach to Predict the Pharmacokinetics of Vancomycin in Critically Ill Septic Patients.一种基于生理的药代动力学建模方法的开发,用于预测重症脓毒症患者中万古霉素的药代动力学
Clin Pharmacokinet. 2017 Jul;56(7):759-779. doi: 10.1007/s40262-016-0475-3.